Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DVAX
1876
DELISTED
Dynavax Technologies
DVAX
| $639K | ﹤0.01% |
51,473
+3
| +0% | +$39 |
|
|
LUCK
1877
Lucky Strike Entertainment
LUCK
$959M
| $639K | ﹤0.01% |
46,617
+20,259
| +77% | +$261K |
|
|
CTLP
1878
DELISTED
Cantaloupe
CTLP
| $638K | ﹤0.01% |
99,321
+60,013
| +153% | +$396K |
|
1879
CTS Corp
CTS
$1.79B
| $637K | ﹤0.01% |
13,611
| – | – |
|
|
DEA
1880
Easterly Government Properties
DEA
$1.15B
| $637K | ﹤0.01% |
22,168
+1
| +0% | +$30 |
|
1881
Ero Copper
ERO
$2.82B
| $637K | ﹤0.01% |
32,994
+7,257
| +28% | +$120K |
|
1882
Empire State Realty Trust
ESRT
$862M
| $636K | ﹤0.01% |
62,859
+9
| +0% | +$89 |
|
1883
Enact Holdings
ACT
$6.63B
| $634K | ﹤0.01% |
20,374
+2
| +0% | +$57 |
|
1884
Mercury Insurance
MCY
$5.91B
| $634K | ﹤0.01% |
12,298
+1
| +0% | +$44 |
|
1885
Sally Beauty Holdings
SBH
$1.46B
| $634K | ﹤0.01% |
50,995
-14
| -0% | -$175 |
|
1886
Karat Packaging
KRT
$803M
| $634K | ﹤0.01% |
22,146
-954
| -4% | -$25.1K |
|
1887
Magnite
MGNI
$2.78B
| $633K | ﹤0.01% |
59,048
+8
| +0% | +$80 |
|
1888
Vera Therapeutics
VERA
$2.37B
| $633K | ﹤0.01% |
14,680
+40
| +0.3% | +$1.43K |
|
|
VGR
1889
DELISTED
Vector Group Ltd.
VGR
| $632K | ﹤0.01% |
57,652
+5
| +0% | +$54 |
|
1890
Apogee Enterprises
APOG
$832M
| $630K | ﹤0.01% |
10,661
-1
| -0% | -$55 |
|
1891
Omnicell
OMCL
$1.69B
| $628K | ﹤0.01% |
21,498
+1
| +0% | +$30 |
|
1892
Protagonist Therapeutics
PTGX
$8.92B
| $628K | ﹤0.01% |
21,735
+1
| +0% | +$27 |
|
1893
Under Armour Class C
UA
$2.85B
| $628K | ﹤0.01% |
87,973
-13
| -0% | -$100 |
|
1894
Digital Turbine
APPS
$990M
| $628K | ﹤0.01% |
239,595
+13,648
| +6% | +$57.9K |
|
1895
Upwork
UPWK
$1.14B
| $627K | ﹤0.01% |
51,210
+5
| +0% | +$68 |
|
1896
Asana
ASAN
$1.83B
| $626K | ﹤0.01% |
40,433
+13
| +0% | +$233 |
|
1897
American Financial Group
AFG
$11.8B
| $625K | ﹤0.01% |
4,582
-528
| -10% | -$65.7K |
|
1898
Helios Technologies
HLIO
$2.57B
| $625K | ﹤0.01% |
13,977
| – | – |
|
1899
BILL Holdings
BILL
$4.52B
| $624K | ﹤0.01% |
9,075
| – | – |
|
1900
Kaiser Aluminum
KALU
$2.61B
| $623K | ﹤0.01% |
6,974
+1
| +0% | +$70 |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.